Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
ESMO Real World Data and Digital Oncology|February 6, 2026
Collaborating across sectors in service of open science, precision oncology, and patients: an overview of the AACR Project GENIE (Genomics Evidence Neoplasia Information Exchange) Biopharma Collaborative (BPC)A Acebedo, P L Bedard, S Brown, et al.
Journal for Immunotherapy of Cancer|March 15, 2019
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)Derek L Clouthier, Scott C Lien, S Y Cindy Yang, et al.
Med (New York, N.Y.)|August 12, 2023
A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trialsAlberto Hernando-Calvo, Maria Vila-Casadesús, Yacine Bareche, et al.
Nature|November 16, 2018
Sensitive tumour detection and classification using plasma cell-free DNA methylomesShu Yi Shen, Rajat Singhania, Gordon Fehringer, et al.
Acta Neuropathologica Communications|October 25, 2021
Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathologySadhana Ravikumar, Laura E M Wisse, Sydney Lim, et al.
Acta Neuropathologica Communications|July 22, 2021
Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregionsL E M Wisse, S Ravikumar, R Ittyerah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
AKT Inhibition in Solid Tumors With AKT1 MutationsDavid M Hyman, Lillian M Smyth, Mark T A Donoghue, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Developing an anatomically valid segmentation protocol for anterior regions of the medial temporal lobe for neurodegenerative diseasesNiyousha Sadeghpour, Sydney A Lim, Anika Wuestefeld, et al.
Hippocampus|July 30, 2025
Developing an Anatomically Valid Segmentation Protocol for Anterior Regions of the Medial Temporal Lobe for Neurodegenerative DiseasesNiyousha Sadeghpour, Sydney A Lim, Anika Wuestefeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
Pageof 30